Meenakshi Anurag

Also affiliated with Children's Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Papers

Driven by 33 papers — median percentile 0. Top paper: “Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy”.

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Cell(2020)10.1016/j.cell.2020.10.036

N/A

8.1DataRank · unranked

565 citations

Eric J. Jaehnig, Shankha Satpathy, Lili M. Blumenberg, Alla Y. Karpova, Meenakshi Anurag +85 more

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Cell(2023)10.1016/j.cell.2023.07.013

N/A

3.5DataRank · unranked

197 citations

Shankara Anand, Yo Akiyama, Tomer M. Yaron, Yizhe Song, Jared L. Johnson +90 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

Cancer Cell(2023)10.1016/j.ccell.2023.07.013

N/A

1.8DataRank · unranked

107 citations

Rita Jui-Hsien Lu, Reyka G. Jayasinghe, Steven M. Foltz, Eduard Porta‐Pardo, Yifat Geffen +95 more

Pan-cancer proteogenomics characterization of tumor immunity

Cell(2024)10.1016/j.cell.2024.01.027

N/A

1.7DataRank · unranked

91 citations

Weiping Ma, Tomer M. Yaron, Francesca Pia Caruso, Nicole Tignor, Joshua M. Wang +95 more

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.07.007

N/A

1.2DataRank · unranked

54 citations

Lizabeth Katsnelson, Marina A. Gritsenko, Yingwei Hu, Boris Reva, Runyu Hong +95 more

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06307-3

N/A

1.1DataRank · unranked

35 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Comprehensive proteogenomic characterization of rare kidney tumors

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101547

N/A

0.920DataRank · unranked

46 citations

Lijun Chen, Yi Hsiao, Rahul Mannan, Yuping Zhang, Jie Luo +95 more

Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101173

N/A

0.843DataRank · unranked

33 citations

Runyu Hong, Elizabeth G. Demicco, Jimin Tan, Rossana Lazcano, André L. Moreira +95 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.02.003

N/A

0.702DataRank · unranked

107 citations

Meenakshi Anurag, Jonathan T. Lei, Jin Cao, Purba Singh, Jianheng Peng +26 more

Multi-scale signaling and tumor evolution in high-grade gliomas

Cancer Cell(2024)10.1016/j.ccell.2024.06.004

N/A

0.612DataRank · unranked

58 citations

Song Cao, Kathleen J. Imbach, Marina A. Gritsenko, T. Mamie Lih, Jennifer Kyle +91 more

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1256

N/A

0.483DataRank · unranked

24 citations

Meenakshi Anurag, Jonathan T. Lei, Beom‐Jun Kim, Purba Singh, Sinem Şeker +16 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0.470DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness

Breast Cancer Research(2022)10.1186/s13058-022-01565-5

N/A

0.464DataRank · unranked

21 citations

Hanan S. Elsarraj, Jonathan T. Lei, Hong Yan, Meenakshi Anurag, Feng Long +10 more

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0044

N/A

0.330DataRank · unranked

8 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets

Cell Genomics(2025)10.1016/j.xgen.2025.100851

N/A

0.254DataRank · unranked

4 citations

Renan Simões, Emerson de Souza Santos, Elizabeth G. Demicco, Rossana N. Lazcano Segura, Ma Weiping +95 more

Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102154

N/A

0.212DataRank · unranked

3 citations

Aranzazu Fernandez-Martinez, Tanmayi D. Vashist, Matthew V. Holt, LaTerrica Williams, Jonathan T. Lei +26 more

Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-23-1173

N/A

0.208DataRank · unranked

3 citations

Shankha Satpathy, Karsten Krug, Jitendra K. Meena, Nivetha Ramesh Babu, Cheyenne Calderon +51 more

Immunogenomic Profiling and Pathological Response Results From a Clinical Trial of Docetaxel and Carboplatin in Triple Negative Breast Cancer

Research Square(2021)10.21203/rs.3.rs-420931/v1

N/A

0.104DataRank · unranked

1 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102255

N/A

0.104DataRank · unranked

1 citations

Yongchao Dou, Meggie N. Young, Alexander B. Saltzman, Meenakshi Anurag, Jonathan T. Lei +20 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0.104DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them?

International Journal of Molecular Sciences(2025)10.3390/ijms262110322

N/A

0DataRank · unranked

1 citations

Ze-Yi Zheng, Meenakshi Anurag, Ahmed Elkhanany, Natalie Chen, Eric C. Chang +1 more

Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy (NET) and subsequent prognosis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.580

N/A

0DataRank · unranked

0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-3106

N/A

0DataRank · unranked

17 citations

Ching Hui Chen, Junkai Wang, Ahmad Bin Salam, Lacey E. Dobrolecki, Alaina Lewis +9 more

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-3484

N/A

0DataRank · unranked

12 citations

Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt +11 more

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0501

N/A

0DataRank · unranked

2 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350.v1

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

(2023)10.1158/2767-9764.c.6752049

N/A

0DataRank · unranked

0 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Data from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

(2023)10.1158/2767-9764.c.6729507.v2

N/A

0DataRank · unranked

0 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

Meenakshi Anurag

Indexed papers

Top data-sharing exemplar

Papers